Cargando…

Diagnostic, Prognostic, and Recurrence Monitoring Value of Plasma CYFRA21-1 and NSE Levels in Patients With Esophageal Squamous Cell Carcinoma

This study was aimed to evaluate the clinical values of single markers and combination in the diagnosis, short-term efficacy and recurrence risk assessment of esophageal squamous cell carcinoma (ESCC). METHODS: Totally 50 patients with I-IVa stage ESCC, 50 healthy controls and 11 patients with recur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ju, Mengyang, Ge, Xiaolin, Di, Xiaoke, Zhang, Yumeng, Liang, Liang, Shi, Yujing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813736/ https://www.ncbi.nlm.nih.gov/pubmed/35127494 http://dx.doi.org/10.3389/fonc.2021.789312

Ejemplares similares

Circulating Tumor Cells in Esophageal Squamous Cell Carcinoma – Mini Review
por: Shi, Yujing, et al.
Publicado: (2021)

Impact of HSP90α, CEA, NSE, SCC, and CYFRA21-1 on Lung Cancer Patients
por: Zhou, Wenwen, et al.
Publicado: (2021)

Retracted: Impact of HSP90α, CEA, NSE, SCC, and CYFRA21-1 on Lung Cancer Patients
por: Healthcare Engineering, Journal of
Publicado: (2023)

The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients
por: Dal Bello, M. G., et al.
Publicado: (2019)

Development and validation of reassigned CEA, CYFRA21-1 and NSE-based models for lung cancer diagnosis and prognosis prediction
por: Yuan, Jingmin, et al.
Publicado: (2022)

Application Value of Serum TK1 and PCDGF, CYFRA21-1, NSE, and CEA plus Enhanced CT Scan in the Diagnosis of Nonsmall Cell Lung Cancer and Chemotherapy Monitoring
por: He, Xiang, et al.
Publicado: (2022)

Increased CYFRA 21-1, CEA and NSE are Prognostic of Poor Outcome for Locally Advanced Squamous Cell Carcinoma in Lung: A Nomogram and Recursive Partitioning Risk Stratification Analysis()()()
por: Wang, Jingbo, et al.
Publicado: (2018)

Markov model and markers of small cell lung cancer: assessing the influence of reversible serum NSE, CYFRA 21-1 and TPS levels on prognosis
por: Boher, J-M, et al.
Publicado: (1999)

Diagnostic Value of CYFRA 21-1 in the Cerebrospinal Fluid for Leptomeningeal Metastasis
por: Zhang, Zhen, et al.
Publicado: (2017)

Prognostic value of serum CYFRA21-1 and CEA for non-small-cell lung cancer
por: Zhang, Zhi-Hui, et al.
Publicado: (2015)

Necrotic related-lncRNAs: Prediction of prognosis and differentiation between cold and hot tumors in head and neck squamous cell carcinoma
por: Shi, Yujing, et al.
Publicado: (2023)

Clinical Value of Tumor Marker Index Based on Preoperative CYFRA 21-1 and SCC-Ag in the Evaluation of Prognosis and Treatment Effectiveness in Patients with Esophageal Squamous Cell Carcinoma
por: Yin, Nanchang, et al.
Publicado: (2020)

Preoperative Cyfra21-1 and SCC-Ag serum titers predict survival in patients with stage II esophageal squamous cell carcinoma
por: Cao, Xun, et al.
Publicado: (2012)

Diagnostic and prognostic values of cerebrospinal fluid CYFRA 21-1 in patients with leptomeningeal carcinomatosis
por: Hyun, Jae-Won, et al.
Publicado: (2017)

Serum markers of CYFRA 21-1 and C-reactive proteins in oral squamous cell carcinoma
por: Hsu, Yin-Ping, et al.
Publicado: (2015)

Estimation of salivary and serum CYFRA 21-1 levels in patients with oral squamous cell carcinoma
por: Adusumilli, Praveena, et al.
Publicado: (2023)

The prognostic value of the tumour marker Cyfra 21-1 in carcinoma of head and neck and its role in early detection of recurrent disease
por: Doweck, I, et al.
Publicado: (2000)

Evaluation of serum cyfra21 in patients with pleural effusion
por: Azimi, Q, et al.
Publicado: (2012)

Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy
por: Gauthé, Mathieu, et al.
Publicado: (2018)

A Comparison of Serum CYFRA 21-1 and SCC Ag in the Diagnosis of Squamous Cell Lung Carcinoma
por: Kim, Young-Chul, et al.
Publicado: (1996)

Diagnostic value analysis of combined detection of Trx, CYFRA21-1 and SCCA in lung cancer
por: Qu, Tao, et al.
Publicado: (2019)

Diagnostic Value of FTO Combined with CEA or CYFRA21-1 in Nonsmall Cell Lung Cancer
por: Shang, Liqun, et al.
Publicado: (2021)

Value of NSE and S100 Protein of Kawasaki Disease with Aseptic Meningitis in Infant
por: Wang, Jiangtao, et al.
Publicado: (2019)

Clinical significance of serum CYFRA 21-1 in gastric cancer.
por: Nakata, B., et al.
Publicado: (1996)

CYFRA 21-1 in urine: a diagnostic marker for endometriosis?
por: Gjavotchanoff, Risto
Publicado: (2015)

On Target: CYFRA 21-1 as an Idiopathic Pulmonary Fibrosis Biomarker
por: Spagnolo, Paolo, et al.
Publicado: (2022)

Methylated PTGER4 is better than CA125, CEA, Cyfra211 and NSE as a therapeutic response assessment marker in stage IV lung cancer
por: Zhang, Yunxia, et al.
Publicado: (2020)

Preoperative CYFRA 21-1 level as a prognostic indicator in resected primary squamous cell lung cancer.
por: Niklinski, J., et al.
Publicado: (1996)

The Need for a CYFRA 21-1 Cutoff Value to Predict Clinical Progression of IPF in Clinical Practice
por: Fujimoto, Hajime, et al.
Publicado: (2022)

Prognostic value of CYFRA 21 − 1 and Ki67 in advanced NSCLC patients with wild-type EGFR
por: Li, Tao, et al.
Publicado: (2023)

Retracted: Diagnostic Value of FTO Combined with CEA or CYFRA21-1 in Nonsmall Cell Lung Cancer
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

CYFRA 21-1 and Placental Growth Factor as Screening Markers for Endometriosis
por: Cho, Hye-yon, et al.
Publicado: (2019)

CYFRA21-1 is a more sensitive biomarker to assess the severity of pulmonary alveolar proteinosis
por: Bai, Jiu-Wu, et al.
Publicado: (2022)

Prognostic value of modified-Gustave-Roussy Immunity Score in resectable proximal gastric cancer
por: Shi, Yujing, et al.
Publicado: (2023)

Diagnostic value of CA‐153 and CYFRA 21‐1 in predicting intraocular metastasis in patients with metastatic lung cancer
por: Lin, Qi, et al.
Publicado: (2019)

Evaluation of the value of preoperative CYFRA21-1 in the diagnosis and prognosis of epithelial ovarian cancer in conjunction with CA125
por: Jin, Chunjing, et al.
Publicado: (2019)

CYFRA 21-1 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value
por: Garcia-Valdecasas Gayo, Sonsoles, et al.
Publicado: (2020)

Diagnostic values of serum tumor markers Cyfra21-1, SCCAg, ferritin, CEA, CA19-9, and AFP in oral/oropharyngeal squamous cell carcinoma
por: Yuan, Chuanshu, et al.
Publicado: (2016)

A role of the Nse4 kleisin and Nse1/Nse3 KITE subunits in the ATPase cycle of SMC5/6
por: Vondrova, Lucie, et al.
Publicado: (2020)

CA-125, CA-153, and CYFRA21-1 as clinical indicators in male lung cancer with ocular metastasis
por: Li, Biao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q3ep7nfjk554k58bdqdm66gflq